Suppressing immunity in advancing MS: too much too late, or too late for much?

Neurology. 2004 Jan 27;62(2):168-9. doi: 10.1212/wnl.62.2.168.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Animals
  • Bone Marrow Transplantation
  • Disease Progression
  • Hematopoietic Stem Cell Transplantation
  • Humans
  • Immunosuppression Therapy*
  • Immunosuppressive Agents / therapeutic use
  • Mitoxantrone / therapeutic use
  • Multiple Sclerosis / drug therapy
  • Multiple Sclerosis / immunology
  • Multiple Sclerosis / therapy*
  • Patient Selection
  • Transplantation Conditioning / adverse effects
  • Transplantation, Autologous
  • Treatment Outcome

Substances

  • Immunosuppressive Agents
  • Mitoxantrone